These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28961736)

  • 1. Performance Validity in Deep Brain Stimulation Candidates.
    Rossetti MA; Collins RL; York MK
    Arch Clin Neuropsychol; 2018 Jun; 33(4):508-514. PubMed ID: 28961736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery.
    Wodushek TR; Domen CH
    Appl Neuropsychol Adult; 2020; 27(1):9-21. PubMed ID: 30183361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Word Memory Test genuine memory impairment profile discriminates genuine memory impairment from invalid performance in a mixed clinical sample with cognitive impairment.
    Alverson WA; O'Rourke JJF; Soble JR
    Clin Neuropsychol; 2019 Nov; 33(8):1420-1435. PubMed ID: 31002017
    [No Abstract]   [Full Text] [Related]  

  • 4. Deep brain stimulation surgery for Parkinson's disease: the role of neuropsychological assessment.
    Amick MM; Grace J
    Med Health R I; 2006 Apr; 89(4):130-3. PubMed ID: 16676908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.
    Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D;
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.
    York MK; Dulay M; Macias A; Levin HS; Grossman R; Simpson R; Jankovic J
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):789-95. PubMed ID: 17965146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of multiple performance and symptom validity measures: Determining the optimal per test cutoff for determination of invalidity, analysis of skew, and inter-test correlations in valid and invalid performance groups.
    Larrabee GJ; Rohling ML; Meyers JE
    Clin Neuropsychol; 2019 Nov; 33(8):1354-1372. PubMed ID: 31111775
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive change on the repeatable battery of neuropsychological status (RBANS) in Parkinson's disease with and without bilateral subthalamic nucleus deep brain stimulation surgery.
    Rinehardt E; Duff K; Schoenberg M; Mattingly M; Bharucha K; Scott J
    Clin Neuropsychol; 2010 Nov; 24(8):1339-54. PubMed ID: 20967688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.
    Aono M; Iga J; Ueno S; Agawa M; Tsuda T; Ohmori T
    J Clin Neurosci; 2014 Sep; 21(9):1595-8. PubMed ID: 24794694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Yágüez L; Costello A; Moriarty J; Hulse N; Selway R; Clough C; Samuel M; Ashkan K
    J Clin Neurosci; 2014 Mar; 21(3):445-50. PubMed ID: 24231557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Rothlind JC; Cockshott RW; Starr PA; Marks WJ
    J Int Neuropsychol Soc; 2007 Jan; 13(1):68-79. PubMed ID: 17166305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological effects of bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Bordini BJ; Garg A; Gallagher CL; Bell B; Garell PC
    Stereotact Funct Neurosurg; 2007; 85(2-3):113-20. PubMed ID: 17228177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Boel JA; Odekerken VJ; Schmand BA; Geurtsen GJ; Cath DC; Figee M; van den Munckhof P; de Haan RJ; Schuurman PR; de Bie RM;
    Parkinsonism Relat Disord; 2016 Dec; 33():90-95. PubMed ID: 27688200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study: Microlesion effects and tremor outcome in the ventrointermediate deep brain stimulation (VIM-DBS).
    Sitburana O; Almaguer M; Ondo WG
    Clin Neurol Neurosurg; 2010 Feb; 112(2):106-9. PubMed ID: 19926209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease.
    van den Wildenberg WP; van Boxtel GJ; van der Molen MW; Bosch DA; Speelman JD; Brunia CH
    J Cogn Neurosci; 2006 Apr; 18(4):626-36. PubMed ID: 16768365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efforts of subthalamic nucleus deep brain stimulation on cognitive spectrum: From explicit to implicit changes in the patients with Parkinson's disease for 1 year.
    You Z; Wu YY; Wu R; Xu ZX; Wu X; Wang XP
    CNS Neurosci Ther; 2020 Sep; 26(9):972-980. PubMed ID: 32436660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
    Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
    Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests.
    Critchfield E; Soble JR; Marceaux JC; Bain KM; Chase Bailey K; Webber TA; Alex Alverson W; Messerly J; Andrés González D; O'Rourke JJF
    Clin Neuropsychol; 2019 Aug; 33(6):1083-1101. PubMed ID: 30475095
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.